DERMA PHARM A/S: Financial statements 2025
CVR: 89453119
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. That is an increase of 14.9% compared with the year before. Equity in the 2025 report amounted to DKK 78,142,000. The solvency ratio was 50.7%. The company had 129 employees in the financial year.
- Gross Profit
- DKK 122,113,000
- Profit/Loss
- DKK 28,500,000
- Equity
- DKK 78,142,000
- Total Assets
- DKK 153,997,000
- Employees
- 129
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 122.1 mio. | 28.5 mio. | 78.1 mio. | 129 |
| 2024 | - | 106.3 mio. | 18.5 mio. | 59.6 mio. | 122 |
| 2023 | - | 81.3 mio. | 9.6 mio. | 46.6 mio. | 117 |
| 2022 | - | 71.2 mio. | 4 mio. | 39.5 mio. | 121 |
| 2021 | - | 70.7 mio. | 7.2 mio. | 39.6 mio. | 115 |
Official annual report
How creditworthy is DERMA PHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 18, 2025, Massimiliano Costantini has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Peter Bogh has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Mikkel Egelund Jensen has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Jean-Yves Paul Etienne Desmottes has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Magdalena Jurkiewicz has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Marie Anne Louise Bozec has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Thomas Dimitri Jacquemet has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Michael Vinther has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Birger Kuntkes has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Brian Lund Mollerup has left the board of directors of DERMA PHARM A/S.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.